Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Shares Outstanding (2024 - 2025)

BioAge Labs (BIOA) has disclosed Shares Outstanding for 2 consecutive years, with $37.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 4.29% to $37.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.4 million through Dec 2025, up 4.29% year-over-year, with the annual reading at $37.4 million for FY2025, 4.29% up from the prior year.
  • Shares Outstanding hit $37.4 million in Q4 2025 for BioAge Labs, up from $35.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $37.4 million in Q4 2025 to a low of $1.7 million in Q1 2024.